Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

Several lines of research suggest that Bcl-xL-mediated anti-apoptotic effects may contribute to the pathogenesis of myeloproliferative neoplasms driven by JAK2V617F and serve as therapeutic target. Here, we used a knock-in JAK2V617F mouse model and confirmed that Bcl-xL was overexpressed in erythroi...

Full description

Bibliographic Details
Main Authors: Coelho-Silva, J.L (Author), Kobayashi, I.S (Author), Kobayashi, S.S (Author), Lima, K. (Author), Lobo de Figueiredo-Pontes, L. (Author), Machado-Neto, J.A (Author), Mantello Bianco, T. (Author), Mishima, Y. (Author), Mullally, A. (Author), Queiroz Arantes Rocha, A. (Author), Takei, H. (Author), Tavares Leal, C. (Author), Welner, R.S (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
Online Access:View Fulltext in Publisher